A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Imatinib in Chordoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)
- Status
- COMPLETED
- Phase
- PHASE4
Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A